Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...

Dipharma completes second phase of CGMP expansion at its Kalamazoo site MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...

Dipharma receives GMP certification from Brazilian ANVISA MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...

India Active Pharmaceutical Ingredient [API] Industry Report BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug...